Successful symptomatic tazarotene treatment of juvenile familial obesity-associated acanthosis nigricans associated with insulin-resistance;Erfolgreiche symptomatische tazarotentherapie der juvenilen acanthosis nigricans vom familiär adipositasassoziierten typ bei insulinresistenz

Hautarzt

Volumn 52, Issue 6, 2001, Pages 499-503

  Weisshaar, E ^a   Bonnekoh, B ^a   Franke, I ^a   Gollnick, H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Acanthosis nigricans; Pediatric dermatology; Tazarotene; Topical retinoids

Indexed keywords

INSULIN; RETINOID; TAZAROTENE; UREA;

ACANTHOSIS NIGRICANS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG FORMULATION; FAMILIAL DISEASE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; INSULIN RESISTANCE; MALE; OBESITY; SCHOOL CHILD; TREATMENT OUTCOME;

ACANTHOSIS NIGRICANS; ADMINISTRATION, TOPICAL; CHILD; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; MALE; NICOTINIC ACIDS; OBESITY; SKIN; TREATMENT OUTCOME; UREA;

EID: 0034987395     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050000083     Document Type: Article

References (16)

1. Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance and acanthosis nigricans
2. Systemische photochemotherapie (PUVA) bei acanthosis nigricans maligna: Regression von keratose, hyperpigmentierung und pruritus
3. Keratin pattern of acanthosis nigricans in syndrome-like association with polythelia, polycystic kidneys and syndactylie
4. Tazarotene gel for Darier's disease
5. Tazarotene - First of a new generation of receptor-selective retinoids
6. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons: A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes
7. Optimizing the use of tazarotene in clinical practice: Consensus statement from the European advisory panel for tazarotene
8. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis
9. Confluent and reticulated papillomatosis: A case with concurrent acanthosis nigricans associated with obesity and insulin resistance
10. Early clinical development of tazarotene
11. Tazarotene gel in childhood Darier disease
12. Die probleme der acanthosis nigricans
13. Acanthosis nigricans
14. Alimentäre fettsucht
15. Topical application of tazarotene in the treatment of nonerythrodermic lamellar ichthyosis
16. Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis